2024. Effectiveness and safety of tuberculin purified protein derivative for the treatment of anogenital warts in patients with human immunodeficiency virus. Dermatology Reports. 16, 3 (Jan. 2024). DOI:https://doi.org/10.4081/dr.2024.9754.